1776 Wealth’s DexCom DXCM Stock Holding History

1776 Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-80	Closed	-$4K	–	324
2019 Q4	$4K	Buy	+80	New	+$3.79K	﹤0.01%	307

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

1776 Wealth's DXCM Position: Q1 2020 in Review

1776 Wealth sold out of DexCom (DXCM) in Q1 2020, closing a stake of 80 shares — an estimated $4K sold.

1776 Wealth first reported a position in DXCM in Q4 2019 and held it in 1 quarter. The position peaked at $4K in Q4 2019. 592 funds tracked by Wall St. Rank hold DXCM as of Q1 2020.

1776 Wealth reported no remaining DexCom position as of Q1 2020 after selling out during the quarter.
1776 Wealth sold 80 DexCom shares in Q1 2020, an estimated $4K.
1776 Wealth first reported a position in DexCom in Q4 2019 and held it in 1 quarter.
1776 Wealth's DexCom position peaked at $4K in Q4 2019.
592 funds tracked by Wall St. Rank held DexCom as of Q1 2020.

Based on 1776 Wealth's 13F filing for Q1 2020, filed 22 Apr 2020.